\name{BuildRN} \alias{BuildRN} %- Also NEED an '\alias' for EACH other topic documented here. \title{ Builds the relevance correlation network } \description{This function builds the relevance correlation network for the genes in the model pathway signature in the given data set.} \usage{ BuildRN(data.m, sign.v, fdr) } %- maybe also 'usage' for other objects documented here. \arguments{ \item{data.m}{Data matrix (numeric). Rows label features, columns label samples. It is assumed that number of features is much larger than number of samples. Rownames must be a valid gene or probe identifier.} \item{sign.v}{Model pathway signature vector (numeric). Elements correspond to the regulatory weights, i.e the sign indicates if up or downregulated. Names of sign.v must be a gene name (probe) identifier which must match the gene (probe) identifier used for the rows of \code{data.m}.} \item{fdr}{Desired false discovery rate (numeric) of significant edges in relevance correlation network.} } \value{ A list with following entries: \item{adj}{Adjacency matrix of inferred relevance network} \item{s}{Model signature vector in data} \item{sd}{Gene signature data matrix} \item{c}{Correlations between signature genes} \item{d}{Data matrix} \item{rep.idx}{Indices of the genes in signature which could be found in data matrix} } \references{{Jiao Y, Lawler K, Patel GS, Purushotham A, Jones AF, Grigoriadis A, Ng T, Teschendorff AE. Denoising algorithm based on relevance network topology improves molecular pathway activity inference. Submitted.} {Teschendorff AE, Gomez S, Arenas A, El-Ashry D, Schmidt M, et al. (2010) Improved prognostic classification of breast cancer defined by antagonistic activation patterns of immune response pathway modules. BMC Cancer 10:604.} } \author{Andrew E Teschendorff, Yan Jiao} \examples{ data(dataDART) rn.o <- BuildRN(dataDART$data, dataDART$sign, fdr=0.05) ## See ?DoDART and vignette('DART') for further examples. } % Add one or more standard keywords, see file 'KEYWORDS' in the % R documentation directory.